Top of page Skip navigation

Programme

 

08:30
Registration and Coffee

Chaired by Mary Clark M: Communications

09:15
Accelerating the commercialisation of cell therapy: Dr Stephen Ward, COO Cell Therapy Catapult
09:35
BI’s culture of engaging with companies as a basis for successful business development strategy: Dr Klaus Mendla, Boehringer Ingelheim
10.00
Investing in Biotech: Dr Kevin Johnson, Partner, Index Ventures: Dr Robert James, Partner, Sixth Element Capital: Dr Debbie Harland, Partner, SR One : Dr Kate Bingham SV Life Sciences : Dr Patrick Verheyen, Head, Johnson & Johnson Innovation, London.
10.50
Coffee Break
Session 1
Maynard 1 Chaired by Philip Oliver

Pre-Clinical

Burdett Theatre chaired by Anthony Walker, Alacrita Consulting

Products in Clinical Trials 

Maynard 2 Chaired by Kevin Byrne Complete Legal

Platform/Diagnostics

11.30
Merus
Critical Pharmaceuticals
Biotec Pharmacon
11.40
Global Acorn
Alloksys
Lein Applied Diagnostics
11.50
Polytherics
Opsona Therapeutics
Arecor
12.00
APIM Therapeutics
Silenseed
VolitionRx
12.10
Cyclacel
ImmuPharma
AvantiCell Science
12.20
Phico Therapeutics
immatics
Pharmidex
12.30
PhotoBiotics
PCI Biotech
Imanova
12:40
Lunch
Session 2
Maynard 1 Chaired by Dr Kieran Rooney, Halo BioConsulting

Pre Clinical

Burdett Theatre Chaired by Vicki Connor, Dalriada Resources

Products in Clinical Trials

Maynard 2 Chaired by Richard Collins. Bio2Business

Platform & Diagnostics

14.00
Selcia
to-BBB
Atlas Genetics
14.10
Epistem
Saturn BioSciences
Horizon Discovery
14.20
Conformetrix
Omnicyte
Octoplus
14.30
reViral
MiNa Therapeutics
CYP Design
14.40
Cytune Pharma
SOM Biotech
DefiniGEN
14.50
BioMoti
Akron Molecules
Pathology Diagnostics
15.00
Elasmogen
OrgaNext Research
Vipergen
15:10
Coffee
Session 3


Burdett Theatre. chaired by Mark Swallow, Citigate Dewe Rogerson

Products in Clinical Trials

Maynard 2, chaired by

Pre-Clin + Platform + Diagnostics

15.50
Avexxin
ProQR Therapeutics
16.00
Bone Therapeutics
Heptares Therapeutics
16.10
BerGen Bio
Glycotope
16.20
Beta-Cell
Numab
16.30
Diabetology
TriMod Therapeutics
16.40
InGell Labs BV
16.50
17:00
Drinks and Networking